EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

MAP kinase phosphatases in metabolic diseases

Ananya Hota, Anton M Bennett

Trends in Endocrinology & Metabolism · 2026-02 · 37 (2) · 124-134

DOI: 10.1016/j.tem.2025.05.002 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Trends in Endocrinology & Metabolism, 2026-02. Verfasst von Ananya Hota und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, Howard University, Washington, DC, USA. Hauptthemen laut MEDLINE: Metabolic Diseases, Mitogen-Activated Protein Kinase Phosphatases. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAMS NIH HHS, NHLBI NIH HHS, Yale Liver Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mitogen-activated protein kinase (MAPK) phosphatases (MKPs) are essential regulators of MAPK signaling pathways. MKPs perform critical roles in various cellular responses by dephosphorylating the regulatory residues and thereby inactivating MAPKs. Many studies have highlighted the role of MKPs in metabolic diseases, including obesity, diabetes, and cardiovascular disorders. These metabolic diseases disrupt key pathways such as insulin signaling, glucose homeostasis, lipid metabolism, and other inflammatory processes. Here, we provide a comprehensive overview of the current understanding of the role played by MKPs in metabolism and highlight their roles in metabolic diseases and potential as therapeutic targets.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Metabolic DiseasesMitogen-Activated Protein Kinase PhosphatasesHumansAnimalsMAP Kinase Signaling System

Stichwörter der Autor:innen

MAPK phosphatasesinflammationinsulin resistancemetabolic diseasesmetabolismmitogen-activated protein kinasesobesitytype 2 diabetes

Substanzen

Mitogen-Activated Protein Kinase Phosphatases

Autor:innen und Institutionen

  • Department of Biology, Howard University, Washington, DC, USA.
  • Department of Pharmacology, Yale University School of Medicine, New Haven, CT, USA; Yale Center for Molecular and Systems Metabolism, Yale University School of Medicine, New Haven, CT, USA. Electronic address: anton.ben…

Förderung

  • NIAMS NIH HHS
  • NHLBI NIH HHS
  • Yale Liver Center

Zitieren

APA

Hota, A., & Bennett, A. M. (2026). MAP kinase phosphatases in metabolic diseases. Trends in Endocrinology & Metabolism, 37(2), 124-134. https://doi.org/10.1016/j.tem.2025.05.002

Vancouver

Hota A, Bennett AM. MAP kinase phosphatases in metabolic diseases. Trends in Endocrinology & Metabolism. 2026;37(2):124-134. doi:10.1016/j.tem.2025.05.002

BibTeX
@article{Hota2026,
  author = {Hota, Ananya and Bennett, Anton M},
  title = {MAP kinase phosphatases in metabolic diseases},
  journal = {Trends in Endocrinology & Metabolism},
  year = {2026},
  volume = {37},
  number = {2},
  pages = {124--134},
  doi = {10.1016/j.tem.2025.05.002}
}
Kostenlos starten →